Refine
Has Fulltext
- yes (16) (remove)
Is part of the Bibliography
- yes (16) (remove)
Year of publication
Document Type
- Doctoral Thesis (9)
- Journal article (7)
Keywords
- diabetes mellitus (16) (remove)
Institute
- Medizinische Klinik und Poliklinik I (7)
- Institut für Klinische Epidemiologie und Biometrie (3)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (2)
- Medizinische Klinik und Poliklinik II (2)
- Medizinische Poliklinik (bis 2004) (2)
- Institut für Anatomie und Zellbiologie (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (1)
- Medizinische Klinik (bis 2004) (1)
- Neurologische Klinik und Poliklinik (1)
EU-Project number / Contract (GA) number
- 294683 (1)
Biomedical research suffers from a dramatically poor translational success. For example, in ischemic stroke, a condition with a high medical need, over a thousand experimental drug targets were unsuccessful. Here, we adopt methods from clinical research for a late-stage pre-clinical meta-analysis (MA) and randomized confirmatory trial (pRCT) approach. A profound body of literature suggests NOX\(_{2}\) to be a major therapeutic target in stroke. Systematic review and MA of all available NOX\(_{2}\)\(^{-/y}\) studies revealed a positive publication bias and lack of statistical power to detect a relevant reduction in infarct size. A fully powered multi-center pRCT rejects NOX\(_{2}\) as a target to improve neurofunctional outcomes or achieve a translationally relevant infarct size reduction. Thus stringent statistical thresholds, reporting negative data and a MA-pRCT approach can ensure biomedical data validity and overcome risks of bias.